We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Centessa Pharmaceuticals PLC | NASDAQ:CNTA | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.54 | -3.36% | 15.54 | 15.00 | 16.88 | 16.26 | 15.44 | 16.08 | 365,616 | 21:02:00 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * Medicxi Ventures Management (Jersey) Ltd | 2. Issuer Name and Ticker or Trading Symbol Centessa Pharmaceuticals plc [ CNTA ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Ordinary Shares (1) | 3/21/2022 | J(2) | 1794211 | A | $0.00 (2) | 11197303 | I | See footnote (3) | ||
Ordinary Shares (1) | 3/21/2022 | J(2) | 45054 | A | $0.00 (2) | 281162 | I | See footnote (4) | ||
Ordinary Shares (1) | 3936970 | I | See footnote (5) | |||||||
Ordinary Shares (1) | 93526 | I | See footnote (6) | |||||||
Ordinary Shares (1) | 4398519 | I | See footnote (7) | |||||||
Ordinary Shares (1) | 55677 | I | See footnote (8) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Remarks: Medicxi Ventures (UK) LLP and Medicxi Ventures (Jersey) Limited act as sub-advisers to Index Ventures Life VI (Jersey) Limited, which acts as the adviser to Index Ventures Life VI (Jersey) LP, and as such, Index Ventures Life VI and Yucca (Jersey) SLP, each of which hold Ordinary Shares as of the date hereof, and the Medicxi Funds may be deemed to be members of a "group" as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended. |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Medicxi Ventures Management (Jersey) Ltd C/O INTERTRUST FUND SERVICES (JERSEY) LIMITED 44 ESPLANADE ST. HELIER, Y9 JE4 9WG | X | ||||
Medicxi Secondary I LP C/O INTERTRUST FUND SERVICES (JERSEY) LIMITED 44 ESPLANADE ST. HELIER, Y9 JE4 9WG | X | ||||
Medicxi Secondary Co-Invest I LP C/O INTERTRUST FUND SERVICES (JERSEY) LIMITED 44 ESPLANADE ST. HELIER, Y9 JE4 9WG | X | ||||
Medicxi Secondary I GP Ltd. C/O INTERTRUST FUND SERVICES (JERSEY) LIMITED 44 ESPLANADE ST. HELIER, Y9 JE4 9WG | X |
Signatures | ||
Medicxi Ventures Management (Jersey) Limited, By: /s/ Francois Chesnay, Its: Director | 3/23/2022 | |
**Signature of Reporting Person | Date | |
Medicxi Secondary I LP, By: Medicxi Ventures Management (Jersey) Limited, By: /s/ Francois Chesnay, Its: Director | 3/23/2022 | |
**Signature of Reporting Person | Date | |
Medicxi Secondary Co-Invest I LP, By: Medicxi Ventures Management (Jersey) Limited, By: /s/ Francois Chesnay, Its: Director | 3/23/2022 | |
**Signature of Reporting Person | Date | |
Medicxi Secondary I GP Limited, By: /s/ Francois Chesnay, Its: Director | 3/23/2022 | |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Centessa Pharmaceuticals Chart |
1 Month Centessa Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions